Searching for dose-response in heart failure clinics: Reply

[Team work, heart failure clinics or specialization in heart failure?].

Searching for New Therapeutic Approaches for Heart Failure

Heart failure (HF) is a major health burden in worldwide. As the end point of numerous cardiovascular diseases, HF is the main cause of disability and death, and its five-year mortality is even higher than that of malignant tumor. The etiologies of heart failure are various, foremost among them is cardiac hypertrophy and myocardial ischemia. We have been committing to research the mechanisms of...

Emerging Drug Therapies for Heart Failure

Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effecti...

Multidisciplinary heart failure clinics: are they effective in Canada?

ACE inhibitors in heart failure. What dose?

Editorial Ace inhibitors in heart failure. What dose? The role of ACE (angiotensin converting enzyme) inhibitors in the treatment of heart failure is now well established. A large body of published work has demonstrated relief of symptoms, increased exercise performance, a reduction in hospital admissions and superiority to conventional vasodilators. Three large survival studies (CONSENSUS-1,' ...